Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 16, 2022; 10(20): 6811-6824
Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.6811
Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.6811
Figure 1 Niigata persistent postural-perceptual dizziness questionnaire score changes after hangebyakujutsutemmato treatment for persistent postural-perceptual dizziness.
A: No statistically significant changes in Niigata persistent postural-perceptual dizziness questionnaire (NPQ) scores were seen in the non-hangebyakujutsutemmato (HBT) group (baseline vs 1 mo, P = 0.98; 1 mo vs 2 mo, P = 0.94; baseline vs 2 mo, P = 0.92); B: In the HBT group, NPQ scores showed a statistically significant decrease (baseline vs 1 mo, P = 0.002; 1 mo vs 2 mo, P = 0.003; baseline vs 2 mo, P < 0.001). bP < 0.01; cP < 0.001. NS: Not significant; NPQ: Niigata PPPD questionnaire; HBT: Hangebyakujutsutemmato; PPPD: Persistent postural-perceptual dizziness.
- Citation: Miwa T, Kanemaru SI. Effects of Kampo medicine hangebyakujutsutemmato on persistent postural-perceptual dizziness: A retrospective pilot study. World J Clin Cases 2022; 10(20): 6811-6824
- URL: https://www.wjgnet.com/2307-8960/full/v10/i20/6811.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i20.6811